Фармакокинетика и Фармакодинамика (Mar 2017)

The antiarrhythmic activity comparative study of Lappaconitine hydrobromide and LMG-124 on the model of aconitine arrhythmia

  • V. N. Stolyaruk,
  • I. B. Tsorin,
  • M. B. Vititnova,
  • T. D. Nikiforova,
  • Yu. I. Murinov,
  • M. S. Yunusov,
  • S. A. Kryzhanovskii

Journal volume & issue
Vol. 0, no. 2
pp. 12 – 15

Abstract

Read online

Two models of the aconitin-induced cardiac arrhythmias were used to compare the antiarrhythmic and antifibrillatory activity of the reference drug Lappaconitine hydrobromide and the LMG-124 compound. It is shown that both compounds have antiarrhythmic action. At the same time, the compound LMG-124 realizes its antiarrhythmic effect in a significantly lower dose. In this case, the compound LMG-124 shows a pronounced antifibrillatory activity, in contrast to the reference drug Lappaconitine hydrobromide, which in the studied dose does not exhibit similar activity.

Keywords